Label: ZILACTIN EARLY RELIEF COLD SORE- benzyl alcohol gel

  • NDC Code(s): 50486-468-02
  • Packager: Blairex Laboratories, Inc.
  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 23, 2021

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Benzyl alcohol 10%

  • Purpose

    Cold sore/fever blister treatment, Oral pain reliever

  • Use

    temporarily relieves pain caused by:

    • cold sores/fever blisters
    • canker sores, mouth sores
    • gum irritations
  • Warnings

    Flammable:

    • keep away from fire or flame

    Stop use and ask a physician if

    • sore mouth symptoms do not improve in 7 days
    • condition worsens or symptoms clear up and occur again within a few days
    • swelling, rash or fever develops
    • irritation, pain or redness persists or worsens
    • apply only to affected area
    • do not exceed recommended dosage
    • avoid contact with the eyes
    • do not use for more than 7 days unless directed by a physician or dentist

    Keep out of reach of children. If swallowed, get medical help or contact a poison control center immediately.

  • Directions

    adults and children
    2 years and older     		dry affected area. Apply with cotton swab or clean finger up to 4 times daily. Allow to dry 30-60 seconds.
    children under 12 years adult supervision should be given in the use of this product
    children under 2 years do not use, consult a physician or dentist
  • Other information

    • do not peel off protective film. Attempting to peel off film may result in skin irritation or tenderness. To remove film, first apply another coat of Zilactin to film, and immediately wipe the area with a moist gauze pad or tissue.
    • contains alcohol 68% by volume
    • store at 15-30°C (59-86°F)
  • Inactive ingredients

    boric acid, hydroxypropylcellulose, propylene glycol, purified water, salicylic acid, SD alcohol 37, tannic acid

    Manufactured for: Blairex Laboratories, Inc. P.O. Box 2127 Columbus, IN 47202 USA

  • QUESTIONS

    Telephone Questions or Comments?
    Call TOLL FREE 1-800-252-4739
    www.zilactin.com

  • PRINCIPAL DISPLAY PANEL

    PROMOTES HEALING

    Cold Sore/Fever Blister/Oral Pain Treatment

    Zilactin ® Early Relief Cold Sore Gel

    • Bioadhesive Promotes Healing
    • Relieves Pain for up to 6 Hours

    Net wt. 0.25 oz (7.1g)

    Principal Display Panel
  • INGREDIENTS AND APPEARANCE
    ZILACTIN   EARLY RELIEF COLD SORE
    benzyl alcohol gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50486-468
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZYL ALCOHOL (UNII: LKG8494WBH) (BENZYL ALCOHOL - UNII:LKG8494WBH) BENZYL ALCOHOL0.1 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    EUCALYPTOL (UNII: RV6J6604TK)  
    THYMOL (UNII: 3J50XA376E)  
    MENTHOL (UNII: L7T10EIP3A)  
    TANNIC ACID (UNII: 28F9E0DJY6)  
    WATER (UNII: 059QF0KO0R)  
    BORIC ACID (UNII: R57ZHV85D4)  
    HYDROXYPROPYL CELLULOSE (TYPE M) (UNII: U3JF91U133)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SALICYLIC ACID (UNII: O414PZ4LPZ)  
    ALCOHOL (UNII: 3K9958V90M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50486-468-021 in 1 CARTON06/30/2005
    17.1 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart35606/30/2005
    Labeler - Blairex Laboratories, Inc. (092575133)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!